Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Polycystic Ovary Syndrome 35Breast Neoplasms 8Obesity 5Neoplasms 5Prostatic Neoplasms 4Insulin Resistance 4Pancreatic Neoplasms 3Infertility 3Endometrial Neoplasms 3Diabetes Mellitus 3Triple Negative Breast Neoplasms 2Neuroendocrine Tumors 2Mouth Neoplasms 2Metabolic Syndrome 2Liver Neoplasms 2Hyperandrogenism 2Diabetes, Gestational 2Diabetes Mellitus, Type 2 2Depression 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Anovulation 2Weight Loss 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1

Interventions

Taxes 1Paclitaxel 1Metformin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Endometrial Adenocarcinoma × Metformin × Clear all
NCT02065687 2021-09-30

Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer

GOG Foundation

Phase 2/3 Unknown
469 enrolled 16 charts
Gynecologic

Endometrial Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡